Companies engaged in biotechnology, pharmaceuticals, research services, home healthcare, hospital operations, long‑term care, and the manufacture and supply of medical equipment and supplies. The sector also includes pharmaceutical retailers and providers of health‑information services. UK‑listed companies in this sector include AstraZeneca plc, GlaxoSmithKline plc, Smith & Nephew plc, Hikma Pharmaceuticals plc, ConvaTec Group plc, Spire Healthcare plc and EMIS Group plc.
Cambridge Cognition Holdings plc (LON:COG), which develops and markets digital solutions to assess brain health, has announced a trading update for the year ended 31 December 2022. Unaudited highlights for..
hVIVO plc (Euronext & LON:HVO) (formerly Open Orphan plc), a rapidly growing specialist contract research organisation (CRO) and world leader in testing infectious and respiratory disease products using human challenge..
Poolbeg Pharma plc (LON:POLB), a leading infectious disease focused biopharmaceutical company, has announced the strategic expansion of POLB 001 into oncology. While investigating the role of cytokine release syndrome in severe influenza, Poolbeg..
Poolbeg Pharma (LON:POLB, OTCQB: POLBF), a leading infectious disease focused biopharmaceutical company, has announced positive initial data analysis for POLB 001, a viral strain agnostic, small molecule immunomodulator being developed..
Nuformix plc (LON:NFX), a pharmaceutical development company targeting unmet medical needs in fibrosis and oncology via drug repurposing, has announced the following update regarding the Company’s NXP004 programme, focused on the..
Cizzle Biotechnology Holdings plc (LON:CIZ), the UK based diagnostics developer, has announced that it has agreed a put option to sell: (i) its 5% economic interest in the commercialisation of..
hVIVO plc (LON:HVO) (formerly Open Orphan plc), a rapidly growing specialist contract research organisation (CRO) and world leader in testing infectious and respiratory disease products using human challenge clinical trials,..
Poolbeg Pharma (LON:POLB, OTCQB: POLBF), a leading infectious disease focused biopharmaceutical company, has announced that it has acquired an exclusive licence from InsuCaps Limited, a sister company of AnaBio Technologies,..
Nuformix plc (LON:NFX), a pharmaceutical development company targeting unmet medical needs in fibrosis and oncology via drug repurposing, has announced its unaudited results for the six months ended 30 September 2022. Operational highlights..
Poolbeg Pharma Plc (LON:POLB, OTCQB: POLBF), a leading infectious disease focused biopharmaceutical company, has announced that, further to its announcement in July 2022, it has now received the initial results..
Goodbody Health (AQSE: GDBY) has announced that Marc Howells has resigned from the Board as Chief Executive Officer, with immediate effect. The Company wishes to thank Marc for his contribution..
Eden Research plc (LON:EDEN), the AIM-quoted company focused on sustainable biopesticides for use in the global crop protection, animal health and consumer products industries, has announced that both of its products..
Poolbeg Pharma plc (LON:POLB, OTCQB: POLBF), a clinical stage infectious disease pharmaceutical company with a unique capital light clinical model, has announced that, further to its announcement in March 2022,..
Cambridge Cognition Holdings Plc (LON:COG), which develops and markets digital solutions to assess brain health, has announced an expansion in the Chinese market through a strategic partnership with Luca Healthcare..
Poolbeg Pharma (LON:POLB, OTCQB: POLBF), a clinical stage infectious disease pharmaceutical company with a unique capital light clinical model, has announced that it will be holding a Capital Markets Day..
Poolbeg Pharma (LON:POLB, OTCQB: POLBF), a clinical stage infectious disease pharmaceutical company with a unique capital light clinical model, has announced that it has made a significant breakthrough in its..
Open Orphan plc (LON:ORPH), a rapidly growing specialist contract research organisation (CRO) and world leader in testing infectious and respiratory disease products using human challenge clinical trials, has announced that..
Cambridge Cognition Holdings Plc (LON:COG), which develops and markets digital solutions to assess brain health, has announced that it has won a £1.1m contract with a major pharmaceutical company to..
Goodbody Health (AQSE: GDBY) has today announced that it has signed an agreement with Allied Pharmacies Limited to join the Goodbody clinic network. The new Allied Pharmacies clinics adds 17..
Goodbody Health (AQSE:GDBY) has announced that it has signed a contract with Tasso Inc, the leading provider of convenient, clinical grade blood collection solutions, for the UK pharmacy and wellness..
